Abstract
The 1H-1,2,3-triazoles have been studied for many years as an important class of heterocyclic compounds and still attracting considerable attention due to their several application such as, organocatalyst, ionic liquid and broad range of biological activities, including several neglected diseases as tuberculosis. This review emphasizes the recent advances of these triazoles and their perspective in the development of new bioactive chemical entities against tuberculosis.
Keywords: Antimycobacterial agents, inhibitors of glycosidases, 1H-1, 2, 3-triazoles, 1, 4-1H-1, 2, 3-triazoles, 1, 4, 5-1H-1, 2, 3- triazoles, tuberculosis.
Current Topics in Medicinal Chemistry
Title:Recent Advances in the Synthesis of New Antimycobacterial Agents Based on the 1H-1,2,3-Triazoles
Volume: 13 Issue: 22
Author(s): Daniel Tadeu G. Gonzaga, David R. da Rocha, Fernando de C. da Silva and Vitor F. Ferreira
Affiliation:
Keywords: Antimycobacterial agents, inhibitors of glycosidases, 1H-1, 2, 3-triazoles, 1, 4-1H-1, 2, 3-triazoles, 1, 4, 5-1H-1, 2, 3- triazoles, tuberculosis.
Abstract: The 1H-1,2,3-triazoles have been studied for many years as an important class of heterocyclic compounds and still attracting considerable attention due to their several application such as, organocatalyst, ionic liquid and broad range of biological activities, including several neglected diseases as tuberculosis. This review emphasizes the recent advances of these triazoles and their perspective in the development of new bioactive chemical entities against tuberculosis.
Export Options
About this article
Cite this article as:
Gonzaga Tadeu G. Daniel, Rocha R. da David, Silva de C. da Fernando and Ferreira F. Vitor, Recent Advances in the Synthesis of New Antimycobacterial Agents Based on the 1H-1,2,3-Triazoles, Current Topics in Medicinal Chemistry 2013; 13 (22) . https://dx.doi.org/10.2174/15680266113136660202
DOI https://dx.doi.org/10.2174/15680266113136660202 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design Subject Index To Volume 13
Current Medicinal Chemistry Anti-Inflammatory Agents from Plants: Progress and Potential
Current Medicinal Chemistry Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes
Current Genomics Recent Development and Future Perspective of Antitubercular Therapy
Anti-Infective Agents in Medicinal Chemistry Simulating the Interactions of Toxins with K+ Channels
Current Pharmaceutical Design Anti-Microbial
Current Bioactive Compounds Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?
Current Drug Safety Differential Gene Expression of <i>ASUN, NEMF, PTPRC</i> and <i>DHX29</i>: Candidate Biomarkers for the Diagnosis of Active and Latent Tuberculosis
Infectious Disorders - Drug Targets Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile
Current Drug Safety Vitamin D Deficiency May Be Associated with a More Rapid Decline in CD4 Cell Count to <350 Cells/µL in Untreated HIV-Infected Adults
Current HIV Research Editorial [Hot Topic: Looking Beyond the Obvious: Search for Novel Targets and Drugs for Reducing the Burden of Infectious Diseases (Guest Editor: Neelima Arora)]
Mini-Reviews in Medicinal Chemistry Rheumatoid Arthritis: An Evolutionary Force in Biologics
Current Pharmaceutical Design Recent Contributions of Elastin-Like Recombinamers to Biomedicine and Nanotechnology
Current Topics in Medicinal Chemistry Studies and Syntheses of Siderophores, Microbial Iron Chelators, and Analogs as Potential Drug Delivery Agents
Current Medicinal Chemistry Recent Advances in the Development of Small-Molecular Inhibitors Target HIV Integrase-LEDGF/p75 Interaction
Mini-Reviews in Medicinal Chemistry COVID-19: Are Experimental Drugs a Cure or Cause?
Current Drug Safety Effects of Alcohol in the Lung
Current Respiratory Medicine Reviews Vascular Wall-Related Biomarkers in Sepsis: A Review of Current Evidence and a Critical Appraisal of Recent Patents
Recent Patents on Biomarkers Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective
Mini-Reviews in Medicinal Chemistry